Trial Profile
A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Oct 2023
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 10 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2010 Status changed from not yet recruiting to recruiting.